News

Salvia BioElectronics’ device is currently being tested in a blinded, sham-controlled study, with two paper-thin implants placed under the skin at the front and back of the head that deliver ...
Bunge Global SA saw profits shrink in the first quarter, adding to the list of crop merchants hit by mounting uncertainty over US trade and biofuel policies. Earnings excluding some items were $1. ...
Eindhoven, the Netherlands, May 27, 2025: Salvia BioElectronics, a clinical-stage medical device company pioneering neuromodulation therapy for people with chronic migraine, today announced the ...
Eindhoven, the Netherlands, May 27, 2025: Salvia BioElectronics, a clinical-stage medical device company pioneering neuromodulation therapy for people with chronic migraine, today announced the ...
Trade tensions between the US and China are stalling agricultural commodity trader Bunge Global SA’s $8.2 billion takeover of Glencore Plc-backed Viterra, according to people familiar with the ...
ST. LOUIS (AP) — ST. LOUIS (AP) — Bunge Global SA (BG) on Wednesday reported first-quarter net income of $201 million. On a per-share basis, the St. Louis-based company said it had net income ...
Bunge Q1 EPS came in at $1.81, topping estimates, as tariff-driven demand shifts offset a 13% drop in sales. The company reaffirmed its 2025 EPS forecast of ~$7.75 and is nearing closure of the ...
Bunge Global SA, the Chesterfield-based agriculture and food business, said its first-quarter profit fell less than expected as demand increased late in the period, fueled by tariff uncertainty ...
CHICAGO, May 7 (Reuters) - Grain trader and processor Bunge Global (BG.N), opens new tab said on Wednesday its first-quarter profit fell less than expected as rising global trade tensions prompted ...
Bunge's Q1 earnings are likely to weaken. Operating conditions are continuing to normalize after the COVID pandemic, even turning into pressure due to agricultural trends. The rising U.S.-China ...
Trade tensions between the U.S. and China are stalling Bunge Global's (NYSE:BG) proposed $8.2B takeover of Glencore-backed (OTCPK:GLCNF) (OTCPK:GLNCY) commodity trader Viterra, Bloomberg reported ...